Cite
MLA Citation
Y. Guan et al.. “A long‐acting pegylated recombinant human growth hormone (Jintrolong®) in healthy adult subjects: Two single‐dose trials evaluating safety, tolerability and pharmacokinetics.” Journal of clinical pharmacy and therapeutics, vol. 43, 2018, pp. 640–646. http://access.bl.uk/ark:/81055/vdc_100067217493.0x00004f